Bioburden Method Suitability for Cleaning and Sanitation Monitoring: How Far Do We Have to Go? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Bioburden Method Suitability for Cleaning and Sanitation Monitoring: How Far Do We Have to Go?
The author reviews test methods for microbiological cleaning processes and suggests ways to improve microbial bioburden method suitability studies.


Pharmaceutical Technology
Volume 34, Issue 8

References

1. R.L. Dyer et al., "Microbiological Tests for Equipment, Containers, Water and Air" in Standard Methods for the Examination of Dairy Products, R.T. Marshall, Ed. 17th ed. (American Public Health Association, Washington, USA, 17th ed., 2004), pp. 328.

2. R. Angelotti et al., Health. Lab. Sci. 1, 289–96 (1964).

3. J.M. Barnes, Proc. Soc. Appl. Bacteriol., 15, 34–40 (1952).

4. G.S. Brown et al., J. of Appl. Microbiol. 103 (4), 1074–1080 (2007).

5. M.S. Favero et al., J. Appl. Bacteriol., 31 (3), 336–43 (1968).

6. L.B. Rose et al., Emerg. Infect. Diseas., 10 (6),1023–1029 (2004).

7. A. Niskanen and M.S. Pohja, J. of Appl. Bacteriol. 42, 53–63 (1977).

8. V. Marshall, S. Poulson-Cook, and J. Moldenhauer, PDA J. Pharm. Sci Technol. 52 (4), 165–169 (1998).

9. S.A. Salo et al., J. of AOAC Intl. 83, 1357–1365 (2000).

10. D. Kang et al., J. of AOAC Intl. 90 (3), 810–816 (2007).

11. J.F. Frank, "Microbial attachment to food and food contact surfaces" in "Advances in Food and Nutrition Research," Taylor, S.L., Ed. (CA. Academic Press, San Diego, Vol. 43, 2001) pp. 320–370.

12. G. Moore and C. Griffith, Dairy, Food, and Environmental Sanitation 22 (6), 410–421 (2002a).

13. G. Moore and C. Griffith, Food Microbiol. 19, 65–73 (2002b).

14. J.W. Costerton et al., Annu. Rev. Microbiol. 49, 711–745 (1995).

15. H.D. Kusumaningrum et al., Intl. J. of Food Microbiol. 85 (3), 227–236 (2003).

16. PDA Technical Report No. 29, "Points to Consider for Cleaning Validation," PDA J. Pharm.Sci. and Tech., 52 (6), 1–23 (1998).

17. FDA, Guide to Inspections of Validation of Cleaning Processes, (Rockville, MD, July 1993).

18. P. Tandon, S. Chhibber, and R.H. Reed, J. of Gen. and Mol. Microbiol., 88 (1), 35–48 (2005).

19. A.P. Williams et al., J. of Appl. Microbiol. 98 (5), 1075–1083 (2005).

20. A.A. Mafu et al., J. of Food Protection, 53 (9), 742–746 (1990).

21. L. B. Rose et al., Emerg. Infect. Diseas., 10 (6), 1023–1029 (2004).

22. D.R. Absolom et al., Appl. and Env. Microbiol., 46 (1), 90–97 (1983).

23. L.O. Egwari, and M.A. Taiwo, West Indian Med. J. 53 (3), 164–169 (2004).

24. H.H.M. Rijnaarts et al., Environ. Sci. Technol. 30 (10), 2877–2883 (1996).

25. W. Lynch, Handbook of Silicone Rubber Fabrication, (Van Nostrand Reinhold, New York, 1978).

26. X. Xie et al., Appl. Microbiol. and Biotech. 73 (3), (2006).

27. G.M. Chudzik, J. Validation Technol. 5 (1), 77–81 (1998).

28. J. Kahovec, R.B. Fox, and K. Hatada, Pure and Applied Chem. 74 (10), 1921–1956 (2002).

29. A.N. Neely and M.P. Maley, J. of Clinic Microbiol., 38 (2), 724–726 (2000).

30. A.N. Neely and M.P. Maley, Am. J. of Infect. Cont. 29 (2), 131–132 (2001).

31. Y. Endo, T. Tani, and M. Kodama, Appl. Environ. Microbiol. 53 (9), 2050–2055 (1987).

32. S. Fidai, S.W. Farer, and R.E. Hancock, Methods Mol. Biol. 78, 187–204 (1997).

33. S.J. Kim, Marine Ecology – Progress Series 26, 203–206 (1985).

34. J.C. Tiller et al., Proc. Natl. Acad. Sci. USA 98 (11), 5981–5985 (2001).

35. G. Reiser, Using Technology to Break the Contamination Chain, Business Briefing: Hospital Engineering and Facilities Management, Issue No. 2 (2005).

36. A. Winn, Medical Plastics and Biomaterials 3 (2), 16–19 (1996).

37. E. Robine, D. Derangere, and D. Robin, Inter. J. of Food Microbiol. 55 (1–3), 229–234 (2000).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here